PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Amyloid blood levels associated with brain changes in Alzheimer's study

The findings that could lead to a new way to detect Alzheimer’s earlier in people with no clinical signs.

2024-03-06
(Press-News.org) New research published today suggests there is a link between abnormal blood levels of amyloid — a protein associated with Alzheimer’s disease — and subtle changes in brain microstructures on a type of MRI, findings that could lead to a new way to detect Alzheimer’s earlier in people with no clinical signs.

Researchers analyzed the results of 128 human participants with and without dementia from the 1Florida Alzheimer’s Disease Research Center who underwent imaging scans using an established diagnostic tool called positron emission tomography, or PET, which can detect amyloid plaques in the brain, a hallmark of Alzheimer’s disease.

Even when a PET scan was negative for amyloid and a participant free of dementia symptoms, researchers found there was an association in those who showed abnormal amyloid levels in the blood and structural abnormalities in the brain detected through a newer method called diffusion MRI, also known as “free-water” imaging.

A team led by investigators from UF's Evelyn F. and William L. McKnight Brain Institute and the Norman Fixel Institute for Neurological Diseases at UF Health reported that the results represent a novel finding that free-water imaging is sensitive to early stages of decline in brain tissue and tiny structures in key parts of the brain — even when a PET scan is negative. The results were published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

“Previously people would say one of the earliest events you would see is amyloid positivity in the brain on a PET scan,” said senior author David Vaillancourt, Ph.D., a professor and chair of the UF College of Health & Human Performance’s department of applied physiology and kinesiology. “Our findings suggest there seem to be events occurring both in the blood and in the brain before you detect amyloid positivity in the brain.”

Blood levels of amyloid were determined using Quest AD-Detect amyloid beta 42/40, a plasma blood test developed by Quest Diagnostics to help assess risk of Alzheimer’s pathology. Collaborators from UF, the University of Miami and Mount Sinai Medical Center in Miami Beach then analyzed diffusion MRI results showing the amount of free-water, or fluid unconstrained by brain tissue.

Two main mechanisms affect free-water: atrophy, which occurs when cells are dying, and inflammation, Vaillancourt said. The new study builds upon his lab’s discovery and validation of free-water imaging as a reliable, noninvasive biomarker for another neurodegenerative malady, Parkinson’s disease.

In the new study, participants who had positive blood tests for amyloid but negative PET scans for amyloid were shown to have brain changes on diffusion MRI, including decreased cortical volume and thickness, increased free-water in 24 outer and inner parts of the brain and decreased tissue microstructure in 66 total regions, as compared to those with a negative amyloid blood test and a negative amyloid PET scan, the researchers reported.

Currently, to assess patients for Alzheimer’s disease, physicians use a combination of medical history, neurological exams, cognitive and functional assessments, and additional tests that may include brain imaging, a spinal tap of cerebrospinal fluid and blood tests. Finding new methods and biomarkers to detect the disease earlier and at less expense could open the door to new clinical trials of experimental drugs to slow, prevent or treat the condition and help intervene sooner with currently available medications, Vaillancourt said.

The next step in this line of research to better correlate these findings, he said, is to follow the participants to see if those with positive amyloid blood tests become amyloid-positive on a PET scan as well as how free-water and blood change over time and how well these changes correlate with symptoms and cognitive testing and eventual clinical diagnosis of Alzheimer’s disease.

“We want to follow them over time to better understand the trajectory of change,” Vaillancourt said.

END


ELSE PRESS RELEASES FROM THIS DATE:

Linkage case management and posthospitalization outcomes in people with HIV

2024-03-06
About The Study: In this randomized clinical trial that involved 500 hospitalized people with HIV, a linkage case management intervention did not reduce 12-month mortality outcomes. These findings may help inform decisions about the potential role of linkage case management among hospitalized people with HIV.  Authors: Robert N. Peck, M.D., Ph.D., of Weill Cornell Medicine in New York, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2024.2177) Editor’s ...

Study quantifies dramatic rise in school shootings and related fatalities since 1970

2024-03-06
Key Takeaways  Incidence of school shootings increasing dramatically: In the 53 years leading up to May 2022, the number of school shootings annually increased more than 12 times.   Children more likely to be victims. The likelihood of children being school shooting victims has increased more than fourfold, and the rate of death from school shootings has risen more than sixfold.    A total of 2,056 school shooting incidents were analyzed: The incidents involved 3,083 victims, including 2,033 children ages 5-17 years, and 1,050 adults ages 18-74 years.  CHICAGO: The ...

New microscopy tech answers fundamental questions

New microscopy tech answers fundamental questions
2024-03-06
The mammalian brain is a web of densely interconnected neurons, yet one of the mysteries in neuroscience is how tools that capture relatively few components of brain activity have allowed scientists to predict behavior in mice. It is hard to believe that much of the brain’s complexity is irrelevant background noise. “We wondered why such a redundant and metabolically costly scheme would have evolved,” says Rockefeller’s Alipasha Vaziri. Now, a new study in Neuron—which presents an unprecedented simultaneous recording of the activity of one million neurons in mice—offers a surprising answer to this fundamental question: technological limitations ...

Moffitt’s Dr. Tiffany Carson joins Global Cancer Grand Challenges team to tackle cancer inequities

Moffitt’s Dr. Tiffany Carson joins Global Cancer Grand Challenges team to tackle cancer inequities
2024-03-06
TAMPA, Fla. — An international interdisciplinary team of researchers, including Moffitt Cancer Center’s Tiffany Carson, Ph.D., has been selected to receive a Cancer Grand Challenges award. Co-founded by the National Cancer Institute and Cancer Research UK, Cancer Grand Challenges supports a community of diverse, global teams to come together, think differently and take on some of cancer’s toughest challenges. Carson is part of the SAMBAI (Societal, Ancestry, Molecular and Biological Analyses of Inequalities) team led by Melissa Davis, Ph.D., from Morehouse School of Medicine. The team will receive up to $25 million over the next five ...

Cancer Grand Challenges selects five new global, interdisciplinary teams to take on four challenges

2024-03-06
Cancer Grand Challenges has selected five new global research teams that will address the following challenges in cancer: reducing cancer inequities, understanding the mechanisms of early-onset cancers, developing drugs for solid tumors in children, and broadening our knowledge about how T cells recognize cancer cells. The winning teams were announced at the Cancer Grand Challenges Summit on March 6, 2024, in London. Cancer Grand Challenges is a global funding initiative cofounded in 2020 by the National Cancer Institute (NCI), ...

25 million US dollars for International Cancer Research

25 million US dollars for International Cancer Research
2024-03-06
The team is co-led by Martin Eilers, Chair of Biochemistry and Molecular Biology at the University of Würzburg (JMU). “Our research project is called KOODAC,” he explains. “That stands for ‘Knocking-Out Oncogenic Drivers and Curing Childhood Cancer’”. Our goal is to develop well-tolerated drugs that can target and eliminate cancer cells in children.” The current standard of care for childhood cancer is chemotherapy and radiation therapy, which, even when successful, are associated with severe side effects. “These ...

3D reflector microchips could speed development of 6G wireless

2024-03-06
ITHACA, N.Y. – Cornell University researchers have developed a semiconductor chip that will enable ever-smaller devices to operate at the higher frequencies needed for future 6G communication technology. The next generation of wireless communication not only requires greater bandwidth at higher frequencies – it also needs a little extra time. The new chip adds a necessary time delay so signals sent across multiple arrays can align at a single point in space-- without disintegrating. The team’s paper, ...

Adverse childhood experiences and adult mental health outcomes

2024-03-06
About The Study: The results of this study using twin data support an association between adverse childhood experiences and poor mental health in adulthood, notwithstanding evidence for familial confounding from shared genetic and environmental factors. These findings suggest that targeted interventions may be associated with reduced risks of future psychopathology.  Authors: Hilda Björk Daníelsdóttir, M.Sc., of the University of Iceland in Reykjavík, Iceland, is the corresponding author. To access the embargoed ...

Symptoms of cognitive impairment among children with atopic dermatitis

2024-03-06
About The Study: The findings of this study suggest that pediatric atopic dermatitis (AD) was generally associated with greater odds of reported difficulties in learning and memory. However, this association was primarily limited to children with neurodevelopmental comorbidities, such as attention-deficit/hyperactivity disorder or learning disabilities. These results may improve the risk stratification of children with AD for cognitive impairments and suggest that evaluation for cognitive difficulties should be prioritized among children with AD and neurodevelopmental disorders.  Authors: Joy ...

Charge fractionalisation observed spectroscopically

Charge fractionalisation observed spectroscopically
2024-03-06
A research team led by the Paul Scherrer Institute has spectroscopically observed fractionalisation of electronic charge in an iron-based metallic ferromagnet. Experimental observation of the phenomenon is not only of fundamental importance. Since it appears in an alloy of common metals at accessible temperatures, it holds potential for future exploitation in electronic devices. The discovery is published in the journal Nature. Basic quantum mechanics tells us that the fundamental unit of charge is unbreakable: the electron charge is quantised. Yet, we have come to understand that exceptions exist. In some situations, ...

LAST 30 PRESS RELEASES:

The complex relationship between fusion fuel and lithium walls

Study refutes blood thinner brain bleed risk after falls in older adults

"Breakthrough in progeria therapy: RNA scissors precisely target and remove mutant gene"

The Mount Sinai Hospital ranked among top in the nation by US News & World Report®

Storage process: a new method reduces the acute toxicity of the essential oil of Artemisia argyi H. Lév. & Vaniot by 40%

Licensed to live

How to survive the explosion of AI slop

GDF-15 and eGFRdiff: Predicting kidney risk and survival in diabetes mellitus

Detecting cancer cells in blood: the development of microchannel devices with microcone arrays

SLAS Discovery: Advancing tools for cancer fibrosis and drug discovery

Researchers create ‘virtual scientists’ to solve complex biological problems

AI-Powered brain stimulation at home could enhance concentration, new research finds

Carbon-based molecules open new pathways for quantum sensing

Immunotherapy for leukemia may affect the bone marrow environment, cancer researchers find

World’s largest tropical peatlands revealed to be more than 40,000 years old

Pick up the pace of your daily walk to boost longevity, experts say

Normal hormone levels trigger severe depression in some women; researcher discovers mechanism

Mexican neuroscientist identifies glutamate biomarker predicting schizophrenia treatment success

Living brain tissue reveals 80% of genes behave differently than assumed

How much time did our ancestors spend up trees? Studying these chimpanzees might help us find out

Discovery of role of gut hormone in chronic diarrhoea could aid development of new tests and treatments

New discovery reveals the spinal cord’s role in bladder control

Kākāpō decline reveals threat of parasite coextinction

Astrocytes identified as hidden culprit behind PTSD

Offering self-collection kits in routine GP appointments could prevent 1,000 women a year from developing cervical cancer

European study offers clearer picture of childhood brain tumor survival

The Lancet: Three in five liver cancer cases due to preventable risk factors; obesity-linked cases on the rise, new analysis suggest

Tiny artificial cells can keep time, study finds

How aging quiets lupus and brings relief to some older patients

Research alert: Synergistic treatment approach supercharges cancer immunotherapy

[Press-News.org] Amyloid blood levels associated with brain changes in Alzheimer's study
The findings that could lead to a new way to detect Alzheimer’s earlier in people with no clinical signs.